Drugs / MK5757
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00848484 | Oct 2008 → Jun 2009 | schizophrenia | Merck Sharp & Dohme LLC | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK5757 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00848484 ↗ |